Tools

A federal advisory panel recommended on Friday that the U.S. Food and Drug Administration approve Gilead Sciences Inc’s experimental hepatitis… »   

Patients infected with the liver-destroying hepatitis C virus should soon have better treatment options as new tablets from Gilead Sciences… »   

For information on how drugs work and affect people, a new study says regulatory reports that are rarely published are… »   

GlaxoSmithKline’s drug sales in China slumped 61 percent in the third quarter, hit by a bribery scandal that damaged its… »   

Shares in Swiss group Actelion climbed more than five percent to their highest since late 2007 on Monday on optimism… »   

Paladin Labs Inc’s experimental drug to treat a rare parasitic disease is effective and safe enough to be approved, an… »   

The FDA today approved macitentan (Opsumit, Actelion ), a new oral endothelin-receptor antagonist that is an enhanced version of the… »   

The share price of Novo Nordisk (NVO) continued to increase following approval from the U.S. Food and Drug Administration… »   

A new type of cholesterol drug being developed by Regeneron Pharmaceuticals Inc and Sanofi SA, when used by itself, cut… »   

Time is running out for a dying Denver father who is pleading with drug companies for access to a… »